Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6362)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rochester CD, Akiyode O. Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient. World J Diabetes 2014; 5(3): 305-315 [PMID: 24936252 DOI: 10.4239/wjd.v5.i3.305] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v5/i3/305.htm |
| Number | Citing Articles |
| 1 |
Bailu Duan, Zhongqiu Zhao, Ling Lin, Jing Jin, Lijun Zhang, Hui Xiong, Na Ta, Tiexiang Gao, Zhinan Mei, Dolores García Giménez. Antidiabetic Effect of Tibetan Medicine Tang‐Kang‐Fu‐San on High‐Fat Diet and Streptozotocin‐Induced Type 2 Diabetic Rats. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/7302965
|
| 2 |
A. A. Spasov, N. I. Chepljaeva, E. S. Vorob’ev. Glycogen phosphorylase inhibitors in the regulation of carbohydrate metabolism in type 2 diabetes. Russian Journal of Bioorganic Chemistry 2016; 42(2): 133 doi: 10.1134/S1068162016020138
|
| 3 |
Elok Rifqi Firdiana, Elga Renjana, Melisnawati H. Angio, Linda Wige Ningrum. Analysis of anti-diabetic property of Aloe vera (L.) Burm.f. by in silico molecular docking. PROCEEDINGS OF THE 9TH INTERNATIONAL SYMPOSIUM ON INNOVATIVE BIOPRODUCTION INDONESIA ON BIOTECHNOLOGY AND BIOENGINEERING 2022: Strengthening Bioeconomy through Applied Biotechnology, Bioengineering, and Biodiversity 2023; 2972: 060004 doi: 10.1063/5.0183377
|
| 4 |
David Miaffo, Fidèle Ntchapda, Talba Abba Mahamad, Barthelemy Maidadi, Albert Kamanyi. Hypoglycemic, antidyslipidemic and antioxydant effects of Vitellaria paradoxa barks extract on high-fat diet and streptozotocin-induced type 2 diabetes rats. Metabolism Open 2021; 9: 100071 doi: 10.1016/j.metop.2020.100071
|
| 5 |
Prateek Sharma, Sukhbir Singh, Neelam Sharma, Deepak Singla, Kumar Guarve, Ajmer Singh Grewal. Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators. Journal of Diabetes & Metabolic Disorders 2022; 21(1): 1129 doi: 10.1007/s40200-022-01019-x
|
| 6 |
Zhengzheng Liao, Jingying Zhang, Bing Liu, Tingxu Yan, Fanxing Xu, Feng Xiao, Bo Wu, Kaishun Bi, Ying Jia. Polysaccharide from Okra (Abelmoschus esculentus (L.) Moench) Improves Antioxidant Capacity via PI3K/AKT Pathways and Nrf2 Translocation in a Type 2 Diabetes Model. Molecules 2019; 24(10): 1906 doi: 10.3390/molecules24101906
|
| 7 |
Maryam Bayanati, Mohammad Ismail Mahboubi Rabbani, Shirin Sirous Kabiri, Bahare Mir, Elham Rezaee, Sayyed Abbas Tabatabai. Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review of Structure-Activity Relationship Studies. Iranian Journal of Pharmaceutical Research 2024; 23(1) doi: 10.5812/ijpr-151581
|
| 8 |
Etheresia Pretorius, Janette Bester, Natasha Vermeulen, Sajee Alummoottil, Prashilla Soma, Antoinette V Buys, Douglas B Kell. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics. Cardiovascular Diabetology 2015; 14(1): 30 doi: 10.1186/s12933-015-0192-5
|
| 9 |
Shubham Kumar, Anu Mittal, Amit Mittal. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors. Bioorganic & Medicinal Chemistry 2021; 46: 116354 doi: 10.1016/j.bmc.2021.116354
|
| 10 |
Bartholomew I. C. Brai, Ruth Ometere Joseph, Titilope Ruth Komolafe, Busayo Elizabeth Amosun, Olamide Olajusi Crown, Kayode Komolafe, Ifedayo Victor Ogungbe. Neem seed oil ameliorates diabetic phenotype by suppressing redox imbalance, dyslipidaemia and pro-inflammatory mediators in a rodent model of type 2 diabetes. Archives of Physiology and Biochemistry 2024; : 1 doi: 10.1080/13813455.2024.2426497
|
| 11 |
A. Galligan, T. M. Greenaway. Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus. Internal Medicine Journal 2016; 46(5): 540 doi: 10.1111/imj.13070
|
| 12 |
Bailu Duan, Zhongqiu Zhao, Weifang Liao, Hui Xiong, Sisi Liu, Liang Yin, Tiexiang Gao, Zhinan Mei. Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San in db/db Mice via Activation of PI3K/Akt and AMPK Pathways. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00535
|
| 13 |
Charles S. Demmer, Lennart Bunch. Benzoxazoles and oxazolopyridines in medicinal chemistry studies. European Journal of Medicinal Chemistry 2015; 97: 778 doi: 10.1016/j.ejmech.2014.11.064
|
| 14 |
Mohd Iqbal Yatoo, Archana Saxena, Arumugam Gopalakris, Mahmoud Alagawany, Kuldeep Dhama. Promising Antidiabetic Drugs, Medicinal Plants and Herbs: An Update. International Journal of Pharmacology 2017; 13(7): 732 doi: 10.3923/ijp.2017.732.745
|
| 15 |
Pratiksha H. Roham, Shreyada N. Save, Shilpy Sharma. Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus. Journal of Pharmaceutical Analysis 2022; 12(4): 556 doi: 10.1016/j.jpha.2022.04.001
|
| 16 |
Himanshu Kumar Bhakta, Pradeep Paudel, Hajime Fujii, Atsuya Sato, Chan Hum Park, Takako Yokozawa, Hyun Ah Jung, Jae Sue Choi. Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting protein tyrosine phosphatase 1B. Archives of Pharmacal Research 2017; 40(11): 1314 doi: 10.1007/s12272-017-0970-6
|
| 17 |
Jiao Luo, Ning Wu, Bo Jiang, Lijun Wang, Shuaiyu Wang, Xiangqian Li, Baocheng Wang, Changhui Wang, Dayong Shi. Marine Bromophenol Derivative 3,4-Dibromo-5-(2-bromo-3,4-dihydroxy-6-isopropoxymethyl benzyl)benzene-1,2-diol Protects Hepatocytes from Lipid-Induced Cell Damage and Insulin Resistance via PTP1B Inhibition. Marine Drugs 2015; 13(7): 4452 doi: 10.3390/md13074452
|
| 18 |
Sung Pyo Hong, Ky Youb Nam, Young June Shin, Kil Won Kim, Soon Kil Ahn. Discovery of 11β-hydroxysteroid dehydrogenase type 1 inhibitor. Bioorganic & Medicinal Chemistry Letters 2015; 25(17): 3501 doi: 10.1016/j.bmcl.2015.06.099
|
| 19 |
Xiaoyu Yin, Ziwei Liu, Gegentuya Huanood, Hayate Sawatari, Keiya Shimamori, Masahiro Kuragano, Kiyotaka Tokuraku. Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging. International Journal of Molecular Sciences 2024; 25(20): 11132 doi: 10.3390/ijms252011132
|
| 20 |
Bogdan-Mircea Mihai, Cristina Mihaela Lăcătuşu, Elena-Daniela Grigorescu, Gina Eosefina Botnariu. Innovative Therapies in Type 2 Diabetes: The Dream of the Future. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2015; 22(4): 341 doi: 10.1515/rjdnmd-2015-0040
|
| 21 |
Rong-Jyh Lin, Yu-Kwan Yen, Chien-Hsing Lee, Su-Ling Hsieh, Yu-Chin Chang, Yung-Shun Juan, Cheng-Yu Long, Kuo-Ping Shen, Bin-Nan Wu. Eugenosedin-A improves obesity-related hyperglycemia by regulating ATP-sensitive K+ channels and insulin secretion in pancreatic β cells. Biomedicine & Pharmacotherapy 2022; 145: 112447 doi: 10.1016/j.biopha.2021.112447
|